Clinical Trial: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diabetes Mellitus, Type 1
Study Type: INTERVENTIONAL
Official Title: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Brief Summary:
This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes.This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose control and BMI in adults with type 2 diabetes.This study aims to look at how well the medication works in people with type 1 diabetes.Semaglutide is not approved by the FDA to be used in this way.These procedures are…
Read more